Press Releases

HealthPartners launches Empower HSA Rx Plus

HealthPartners is working to ensure that members who have a high-deductible health plan (HDHP) and a health savings account (HSA) have more affordable access to preventive prescription drugs through the launch of the Empower HSA Rx Plus plan....

CoreLab Partners collaborates at industry conferences worldwide

CoreLab Partners, Inc, a leading independent core lab providing centralized cardiac safety services and medical imaging assessment, is set to attend and actively participate in several upcoming industry events around the world over the next several months. ...

IntegenX Names Biotechnology Veteran David V. Smith Chief Operating Officer

IntegenX Inc., a privately held company and leading developer of rapid human DNA identification technology, DNA sequencing library preparation systems, and DNA/RNA room temperature stability and storage products, today announced the appointment of David V. Smith as Chief...

Pfizer To Present New Data In Advanced Kidney, Lung And Hematologic Cancers At 2012 ASCO Annual Meeting

New data will be presented on targeted cancer treatments from the Pfizer Oncology portfolio across three key therapeutic categories, including tumors of the kidney, lung and hematologic malignancies, at the Annual Meeting of the American Society of Clinical...

Dyax Corp. Launches Hereditary Angioedema Attack Tracker™, a Free iPhone Application for HAE Patients

Dyax Corp.today announced the launch of a free smartphone application for the iPhone – HAE Attack Tracker™. This application allows HAE patients to keep detailed records of their disease related information, including emergency and physician contacts as well...

BioRx Affirms Strong Supply of C1 Esterase Inhibitor Product

In response to reports of a shortage of one C1 esterase inhibitor product on the market, BioRx affirmed today that its supply of Berinert® remains strong and can immediately accommodate increased demand. The statement was in response to...

Emerging Biopharmaceutical Markets to Witness Exponential Growth

IMARC Group, one of the world‘s leading research and advisory firms, finds in its new report “Global Biopharmaceutical Market Report & Forecast 2010-2015” that driven by a huge patient pool, rapid economic growth and improving intellectual property rights,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read